15569263|t|Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor.
15569263|a|Epidemiological studies show reduced risk of Alzheimer's disease (AD) among patients using non-steroidal inflammatory drugs (NSAID) indicating the role of inflammation in AD. Studies have shown a chronic CNS inflammatory response associated with increased accumulation of amyloid peptide and activated microglia in AD. Our previous studies showed that interaction of Abeta1-40 or fibrilar Abeta1-42 caused activation of nuclear transcription factor, early growth response-1 (Egr-1), which resulted in increased expression of cytokines (TNF-alpha and IL-1beta) and chemokines (MIP-1beta, MCP-1 and IL-8) in monocytes. We determined whether curcumin, a natural product known to have anti-inflammatory properties, suppressed Egr-1 activation and concomitant expression of cytochemokines. We show that curcumin (12.5-25 microm) suppresses the activation of Egr-1 DNA-binding activity in THP-1 monocytic cells. Curcumin abrogated Abeta1-40-induced expression of cytokines (TNF-alpha and IL-1beta) and chemokines (MIP-1beta, MCP-1 and IL-8) in both peripheral blood monocytes and THP-1 cells. We found that curcumin inhibited Abeta1-40-induced MAP kinase activation and the phosphorylation of ERK-1/2 and its downstream target Elk-1. We observed that curcumin inhibited Abeta1-40-induced expression of CCR5 but not of CCR2b in THP-1 cells. This involved abrogation of Egr-1 DNA binding in the promoter of CCR5 by curcumin as determined by: (i) electrophoretic mobility shift assay, (ii) transfection studies with truncated CCR5 gene promoter constructs, and (iii) chromatin immunoprecipitation analysis. Finally, curcumin inhibited chemotaxis of THP-1 monocytes in response to chemoattractant. The inhibition of Egr-1 by curcumin may represent a potential therapeutic approach to ameliorate the inflammation and progression of AD.
15569263	0	8	Curcumin	Chemical	MESH:D003474
15569263	55	70	amyloid peptide	Chemical	-
15569263	113	117	CCR5	Gene	1234
15569263	141	146	THP-1	CellLine	CVCL:0006
15569263	262	281	Alzheimer's disease	Disease	MESH:D000544
15569263	283	285	AD	Disease	MESH:D000544
15569263	293	301	patients	Species	9606
15569263	308	340	non-steroidal inflammatory drugs	Chemical	-
15569263	342	347	NSAID	Chemical	-
15569263	372	384	inflammation	Disease	MESH:D007249
15569263	388	390	AD	Disease	MESH:D000544
15569263	425	437	inflammatory	Disease	MESH:D007249
15569263	489	504	amyloid peptide	Chemical	-
15569263	532	534	AD	Disease	MESH:D000544
15569263	667	690	early growth response-1	Gene	1958
15569263	692	697	Egr-1	Gene	1958
15569263	753	762	TNF-alpha	Gene	7124
15569263	767	775	IL-1beta	Gene	3553
15569263	793	802	MIP-1beta	Gene	6351
15569263	804	809	MCP-1	Gene	6347
15569263	814	818	IL-8	Gene	3576
15569263	856	864	curcumin	Chemical	MESH:D003474
15569263	903	915	inflammatory	Disease	MESH:D007249
15569263	939	944	Egr-1	Gene	1958
15569263	1015	1023	curcumin	Chemical	MESH:D003474
15569263	1070	1075	Egr-1	Gene	1958
15569263	1100	1105	THP-1	CellLine	CVCL:0006
15569263	1123	1131	Curcumin	Chemical	MESH:D003474
15569263	1185	1194	TNF-alpha	Gene	7124
15569263	1199	1207	IL-1beta	Gene	3553
15569263	1225	1234	MIP-1beta	Gene	6351
15569263	1236	1241	MCP-1	Gene	6347
15569263	1246	1250	IL-8	Gene	3576
15569263	1291	1296	THP-1	CellLine	CVCL:0006
15569263	1318	1326	curcumin	Chemical	MESH:D003474
15569263	1404	1411	ERK-1/2	Gene	5595;5594
15569263	1438	1443	Elk-1	Gene	2002
15569263	1462	1470	curcumin	Chemical	MESH:D003474
15569263	1513	1517	CCR5	Gene	1234
15569263	1529	1534	CCR2b	Gene	729230
15569263	1538	1543	THP-1	CellLine	CVCL:0006
15569263	1579	1584	Egr-1	Gene	1958
15569263	1616	1620	CCR5	Gene	1234
15569263	1624	1632	curcumin	Chemical	MESH:D003474
15569263	1734	1738	CCR5	Gene	1234
15569263	1824	1832	curcumin	Chemical	MESH:D003474
15569263	1857	1862	THP-1	CellLine	CVCL:0006
15569263	1923	1928	Egr-1	Gene	1958
15569263	1932	1940	curcumin	Chemical	MESH:D003474
15569263	2006	2018	inflammation	Disease	MESH:D007249
15569263	2038	2040	AD	Disease	MESH:D000544
15569263	Negative_Correlation	MESH:D003474	MESH:D007249
15569263	Negative_Correlation	MESH:D003474	6351
15569263	Association	1234	1958
15569263	Negative_Correlation	MESH:D003474	1958
15569263	Negative_Correlation	MESH:D003474	5594
15569263	Negative_Correlation	MESH:D003474	2002
15569263	Negative_Correlation	MESH:D003474	7124
15569263	Negative_Correlation	MESH:D003474	3576
15569263	Negative_Correlation	MESH:D003474	MESH:D000544
15569263	Negative_Correlation	MESH:D003474	3553
15569263	Negative_Correlation	MESH:D003474	1234
15569263	Negative_Correlation	MESH:D003474	5595
15569263	Negative_Correlation	MESH:D003474	6347

